NZ's AFT Pharmaceuticals set for best day in 7 months on FDA nod for tablet launch

AFT Pharmaceuticals

02/03/2023 24:40

** Shares of AFT Pharmaceuticals Ltd  AFT.NZ  jump as much
as 8.3% to NZ$3.64, on track for best day since July 7, if gains
hold 
    ** The pharmaceutical firm says the U.S. FDA approved rapid
release tablet form of Maxigesic for management of
mild-to-moderate acute pain
    ** Stock hits highest since Feb 20
    ** More than 26,159 shares change hands, vs the 30-day
average volume of 10,997 shares
    

 (Reporting by Poonam Behura in Bengaluru)
 ((Poonam.Behura@thomsonreuters.com;))